Screener
Insmed INSM Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by Insmed in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromIssuanceOfCommonStock.
The source filing: Insmed’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 6:59 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104506-26-000041
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Net cash provided by investing activities | 290,033 | 308,247 |
| Financing activities | ||
| Proceeds from exercise of stock options and ESPP | 58,319 | 66,669 |
| Proceeds from issuance of common stock, net | — | 823,538 |
| Payments of principal of 0.75% convertible senior notes due 2028 | — | (1,965) |
| Payments of finance lease principal | (1,626) | (1,438) |
| Net cash provided by financing activities | 56,693 | 886,804 |
| Effect of exchange rates on cash and cash equivalents | (840) | 1,900 |
Item 1C. Consolidated Financial Statements
FAQ
- What is Insmed's stock issuance proceeds?
- Insmed (INSM) reported stock issuance proceeds of -$30.31M in Q2 2026.
- How has Insmed's stock issuance proceeds changed year-over-year?
- Insmed's stock issuance proceeds decreased by 103.8% year-over-year, from $793.83M to -$30.31M.
- What is the long-term trend for Insmed's stock issuance proceeds?
- Over 2 years (2022 to 2024), Insmed's stock issuance proceeds has grown at a 92.6% compound annual growth rate (CAGR), from $292.15M to $1.08B.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.
Ask your AI about Insmed's stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude